[1]
Mehak, M. et al. 2022. Molecular Screening & Influence of Cyp2C9*2 Variant with HHC in CVD Patients. Journal of Science & Technology (JST). 7, 5 (Jul. 2022), 179–184. DOI:https://doi.org/10.46243/jst.2022.v7.i05.pp179-184.